Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | MMP12 | P39900 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CRAT | P43155 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9336407 | 0.85 | KDM4E (0.44) | KDM4ECA2PTGS1MMP12NFKB1 | |
| SCHEMBL4961544 | 0.81 | SMN1; SMN2 (0.39) | KDM4ECA2PTGS1MMP12NFKB1 | |
| SCHEMBL143910 | 0.78 | KDM4E (0.48) | KDM4ECA2PTGS1MMP12NFKB1 | |
| SCHEMBL6970706 | 0.78 | FFAR3 (0.35) | KDM4ECA2PTGS1MMP12NFKB1 | |
| SCHEMBL964570 | 0.75 | LMNA (0.50) | KDM4ECA2MAPTTHRBALOX15 | |
| SCHEMBL12959118 | 0.75 | CRBN (0.41) | CA2NFKB1ALOX15THPOBLM | |
| SCHEMBL9614381 | 0.75 | KDM4E (0.46) | KDM4ECA2PTGS1MMP12NFKB1 | |
| SCHEMBL1471075 | 0.73 | SMN1; SMN2 (0.42) | KDM4ECA2PTGS1MMP12NFKB1 | |
| SCHEMBL9614376 | 0.73 | CRAT (0.38) | KDM4ECA2PTGS1MMP12NFKB1 | |
| SCHEMBL3869217 | 0.73 | KDM4E (0.44) | KDM4ECA2PTGS1MMP12NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7964640-B2 | Oligomers of straight-chain and unbranched fatty acids and drugs containing these | PLT PATENT & LICENSE TRADING LTD. (GB) | 2011-06-21 | — | — | US | disclosed |
| US-7964640-B2 | Oligomers of straight-chain and unbranched fatty acids and drugs containing these | PLT PATENT & LICENSE TRADING LTD. (GB) | 2011-06-21 | — | — | US | disclosed |
| US-20090012166-A1 | Oligomers of Straight-Chain and Unbranched Fatty Acids and Drugs Containing These | PLT PATENT & LICENSE TRADING S.L. (ES) | 2009-01-08 | — | — | US | disclosed |
| US-20090012166-A1 | Oligomers of Straight-Chain and Unbranched Fatty Acids and Drugs Containing These | PLT PATENT & LICENSE TRADING S.L. (ES) | 2009-01-08 | — | — | US | disclosed |
| EP-1329160-A2 | 4-ACYLAMINOPYRAZOLE DERIVATIVES | Sankyo Company, Limited (JP) | 2003-07-23 | — | — | EP | disclosed |
| US-3993656-A | BRONCHODILATOR, HYPOTENSIVES | MERCK & CO., INC. (US) | 1976-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090012166-A1 | Oligomers of Straight-Chain and Unbranched Fatty Acids and Drugs Containing These | FASN, FFAR3, FFAR2 | KDM4E 4720/4885CA2 4330/4885PTGS1 314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.